{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:47:31Z","timestamp":1792064851917,"version":"4.4.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T00:00:00Z","timestamp":1558656000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T00:00:00Z","timestamp":1558656000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13023-019-1089-2","type":"journal-article","created":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:03:22Z","timestamp":1558699402000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Linear IgA bullous dermatosis in adults and children: a clinical and immunopathological study of 38 patients"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7636-958X","authenticated-orcid":false,"given":"Giovanni","family":"Genovese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigia","family":"Venegoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Fanoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Muratori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Berti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Valerio","family":"Marzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,24]]},"reference":[{"key":"1089_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.clindermatol.2011.03.008","volume":"30","author":"G Fortuna","year":"2012","unstructured":"Fortuna G, Marinkovich MP. Linear immunoglobulin a bullous dermatosis. Clin Dermatol. 2012;30:38\u201350.","journal-title":"Clin Dermatol"},{"key":"1089_CR2","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1046\/j.1365-4362.1999.00813.x","volume":"38","author":"CA Egan","year":"1999","unstructured":"Egan CA, Zone JJ. Linear IgA bullous dermatosis. Int J Dermatol. 1999;38:818\u201327.","journal-title":"Int J Dermatol"},{"key":"1089_CR3","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/bjd.15232","volume":"177","author":"C Ohata","year":"2017","unstructured":"Ohata C, Ishii N, Koga H, Nakama T. A clinical and serological study of linear IgA bullous dermatosis without linear immunoglobulin deposition other than IgA at the basement membrane zone using direct immunofluorescence. Br J Dermatol. 2017;177:152\u20137.","journal-title":"Br J Dermatol"},{"key":"1089_CR4","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1111\/pde.12684","volume":"32","author":"YL Kong","year":"2015","unstructured":"Kong YL, Lim YL, Chandran NS. Retrospective study on autoimmune blistering disease in Paediatric patients. Pediatr Dermatol. 2015;32:845\u201352.","journal-title":"Pediatr Dermatol"},{"key":"1089_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/0738-081X(91)90031-F","volume":"9","author":"S Jab\u0142o\u0144ska","year":"1991","unstructured":"Jab\u0142o\u0144ska S, Chorzelski TP, Rosinska D, Maciejowska E. Linear IgA bullous dermatosis of childhood (chronic bullous dermatosis of childhood). Clin Dermatol. 1991;9:393\u2013401.","journal-title":"Clin Dermatol"},{"key":"1089_CR6","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/S0190-9622(88)70236-4","volume":"19","author":"F Wojnarowska","year":"1988","unstructured":"Wojnarowska F, Marsden RA, Bhogal B, Black MM. Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap. J Am Acad Dermatol. 1988;19:792\u2013805.","journal-title":"J Am Acad Dermatol"},{"key":"1089_CR7","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/j.0736-8046.2004.21521.x","volume":"21","author":"AJ Kanwar","year":"2004","unstructured":"Kanwar AJ, Sandhu K, Handa S. Chronic bullous dermatosis of childhood in North India. Pediatr Dermatol. 2004;21:610\u20132.","journal-title":"Pediatr Dermatol"},{"key":"1089_CR8","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1525-1470.2006.00279.x","volume":"23","author":"A Nanda","year":"2006","unstructured":"Nanda A, Dvorak R, Al-Sabah H, Alsaleh QA. Linear IgA bullous disease of childhood: an experience from Kuwait. Pediatr Dermatol. 2006;23:443\u20137.","journal-title":"Pediatr Dermatol"},{"key":"1089_CR9","doi-asserted-by":"crossref","unstructured":"Kharfi M, Khaled A, Karaa A, Zaraa I, Fazaa B, Kamoun MR. Linear IgA bullous dermatosis: the more frequent bullous dermatosis of children. Dermatol Online J. 2010;16(2).","DOI":"10.5070\/D32TS975M4"},{"key":"1089_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1525-1470.2008.00817.x","volume":"26","author":"N Kenani","year":"2009","unstructured":"Kenani N, Mebazaa A, Denguezli M, Ghariani N, Sriha B, Belajouza C, Nouira R. Childhood linear IgA bullous dermatosis in Tunisia. Pediatr Dermatol. 2009;26:28\u201333.","journal-title":"Pediatr Dermatol"},{"key":"1089_CR11","first-page":"434","volume":"7","author":"F Bertram","year":"2009","unstructured":"Bertram F, Brocker EB, Zillikens D, Schmidt E. Prospective analysis of the incidence of autoimmune bullous disorders in lower Franconia, Germany. J Dtsch Dermatol Ges. 2009;7:434\u201340.","journal-title":"J Dtsch Dermatol Ges"},{"key":"1089_CR12","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/j.1365-4632.2006.02750.x","volume":"45","author":"GK Mulyowa","year":"2006","unstructured":"Mulyowa GK, Jaeger G, Kabakyenga J, Br\u00f6cker EB, Zillikens D, Schmidt E. Autoimmune subepidermal blistering diseases in Uganda: correlation of autoantibody class with age of patients. Int J Dermatol. 2006;45:1047\u201352.","journal-title":"Int J Dermatol"},{"key":"1089_CR13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1365-2133.1988.tb03197.x","volume":"119","author":"SE Kelly","year":"1988","unstructured":"Kelly SE, Frith PA, Millard PR, Wojnarowska F, Black MM. A clinicopathological study of mucosal involvement in linear IgA disease. Br J Dermatol. 1988;119:161\u201370.","journal-title":"Br J Dermatol"},{"key":"1089_CR14","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/bjd.15244","volume":"177","author":"J Gottlieb","year":"2017","unstructured":"Gottlieb J, Ingen-Housz-Oro S, Alexandre M, et al. Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case series of 72 adults. Br J Dermatol. 2017;177:212\u201322.","journal-title":"Br J Dermatol"},{"key":"1089_CR15","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/bcp.13827","volume":"85","author":"B Garel","year":"2019","unstructured":"Garel B, Ingen-Housz-Oro S, Afriat D, et al. Drug-induced linear IgA bullous dermatosis: a French retrospective pharmacovigilance study of 69 cases. Br J Clin Pharmacol. 2019;85:570\u20139.","journal-title":"Br J Clin Pharmacol"},{"key":"1089_CR16","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/bjd.12488","volume":"169","author":"J Chanal","year":"2013","unstructured":"Chanal J, Ingen-Housz-Oro S, Ortonne N, et al. Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms. Br J Dermatol. 2013;169:1041\u20138.","journal-title":"Br J Dermatol"},{"key":"1089_CR17","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.jaad.2011.09.018","volume":"66","author":"G Fortuna","year":"2012","unstructured":"Fortuna G, Salas-Alanis JC, Guidetti E, Marinkovich MP. A critical reappraisal of the current data on drug-induced linear immunoglobulin a bullous dermatosis: a real and separate nosological entity? J Am Acad Dermatol. 2012;66:988\u201394.","journal-title":"J Am Acad Dermatol"},{"key":"1089_CR18","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1001\/archderm.1991.01680010138031","volume":"127","author":"A Fuligni","year":"1991","unstructured":"Fuligni A, Di Blasi A, Borgogni L, Pimpinelli N, Moretti S, Fabbri P. A peculiar case of linear IgA bullous dermatosis. Arch Dermatol. 1991;127:126\u20137.","journal-title":"Arch Dermatol"},{"key":"1089_CR19","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/S0190-9622(94)70252-7","volume":"31","author":"G Zambruno","year":"1994","unstructured":"Zambruno G, Manca V, Kanitakis J, Cozzani E, Nicolas JF, Giannetti A. Linear IgA bullous dermatosis with autoantibodies to a 290 kd antigen of anchoring fibrils. J Am Acad Dermatol. 1994;31:884\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"1089_CR20","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1046\/j.1365-2133.1996.d01-1128.x","volume":"135","author":"G Zambruno","year":"1996","unstructured":"Zambruno G, Kanitakis J. Linear IgA dermatosis with IgA antibodies to type VII collagen. Br J Dermatol. 1996;135:1004\u20135.","journal-title":"Br J Dermatol"},{"key":"1089_CR21","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1159\/000246123","volume":"194","author":"R Pellicano","year":"1997","unstructured":"Pellicano R, Lomuto M, Cozzani E, Iannantuono M, De Simone C. Linear IgA bullous dermatosis after contact with sodium hypochlorite. Dermatology. 1997;194:284\u20136.","journal-title":"Dermatology"},{"key":"1089_CR22","first-page":"48","volume":"8","author":"C De Simone","year":"1998","unstructured":"De Simone C, Guerriero C, Pellicano R. Linear IgA disease and ulcerative colitis. Eur J Dermatol. 1998;8:48\u201350.","journal-title":"Eur J Dermatol"},{"key":"1089_CR23","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1111\/j.1365-4632.2007.03317.x","volume":"46","author":"G Viglizzo","year":"2007","unstructured":"Viglizzo G, Cozzani E, Nozza P, Occella C, Parodi A. A case of linear IgA disease in a child with IgA and IgG circulating antibodies directed to BPAg2. Int J Dermatol. 2007;46:1302\u20134.","journal-title":"Int J Dermatol"},{"key":"1089_CR24","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1080\/09546630801958246","volume":"19","author":"AV Marzano","year":"2008","unstructured":"Marzano AV, Ramoni S, Spinelli D, Alessi E, Berti E. Refractory linear IgA bullous dermatosis successfully treated with mycophenolate sodium. J Dermatolog Treat. 2008;19:364\u20137.","journal-title":"J Dermatolog Treat"},{"key":"1089_CR25","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1111\/j.1365-4632.2011.05138.x","volume":"51","author":"E Antiga","year":"2012","unstructured":"Antiga E, Bellandi S, Bianchi B, et al. A further case of subacute prurigo-like linear IgA bullous dermatosis: growing evidence of a new subset. Int J Dermatol. 2012;51:1500\u20131.","journal-title":"Int J Dermatol"},{"key":"1089_CR26","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1001\/jamapediatrics.2013.2565","volume":"167","author":"G Paloni","year":"2013","unstructured":"Paloni G, Shardlow A, Maschio M, Berti I, Taddio A, Ventura A. A child with bullous skin lesions. Linear IgA dermatosis. JAMA Pediatr. 2013;167:975\u20136.","journal-title":"JAMA Pediatr"},{"key":"1089_CR27","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.2340\/00015555-2074","volume":"95","author":"L Romani","year":"2015","unstructured":"Romani L, Diociaiuti A, D'Argenio P, et al. A case of neonatal linear IgA bullous dermatosis with severe eye involvement. Acta Derm Venereol. 2015;95:1015\u20137.","journal-title":"Acta Derm Venereol"},{"key":"1089_CR28","doi-asserted-by":"publisher","first-page":"e333","DOI":"10.1111\/jdv.14120","volume":"31","author":"A Diociaiuti","year":"2017","unstructured":"Diociaiuti A, Zambruno G, Diomedi Camassei F, et al. IgA tracheobronchial deposits underlie respiratory compromise in neonatal linear IgA bullous dermatosis. J Eur Acad Dermatol Venereol. 2017;31:e333\u20135.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1089_CR29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1684\/ejd.2017.3030","volume":"27","author":"A Gatto","year":"2017","unstructured":"Gatto A, Guerriero C, Moretta G, et al. Linear IgA bullous dermatosis in a two-year-old child: possible association with aspirin. Eur J Dermatol. 2017;27:417\u20138.","journal-title":"Eur J Dermatol"},{"key":"1089_CR30","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1365-2133.1982.tb00360.x","volume":"107","author":"JN Leonard","year":"1982","unstructured":"Leonard JN, Haffenden GP, Ring NP, et al. Linear IgA disease in adults. Br J Dermatol. 1982;107:301\u201316.","journal-title":"Br J Dermatol"},{"key":"1089_CR31","first-page":"370","volume":"138","author":"LS Chan","year":"2002","unstructured":"Chan LS, Ahmed AR, Anhalt GJ, et al. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol. 2002;138:370\u20139.","journal-title":"Arch Dermatol"},{"key":"1089_CR32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239\u201345.","journal-title":"Clin Pharmacol Ther"},{"key":"1089_CR33","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/j.1346-8138.2008.00561.x","volume":"35","author":"Y Horiguchi","year":"2008","unstructured":"Horiguchi Y, Ikoma A, Sakai R, Masatsugu A, Ohta M, Hashimoto T. Linear IgA dermatosis: report of an infantile case and analysis of 213 cases in Japan. J Dermatol. 2008;35:737\u201343.","journal-title":"J Dermatol"},{"key":"1089_CR34","doi-asserted-by":"publisher","first-page":"466","DOI":"10.2340\/00015555-1990","volume":"95","author":"K Lings","year":"2015","unstructured":"Lings K, Bygum A. Linear IgA bullous dermatosis: a retrospective study of 23 patients in Denmark. Acta Derm Venereol. 2015;95:466\u201371.","journal-title":"Acta Derm Venereol"},{"key":"1089_CR35","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1365-2230.2012.04383.x","volume":"37","author":"AR Shipman","year":"2012","unstructured":"Shipman AR, Reddy H, Wojnarowska F. Association between the subepidermal autoimmune blistering diseases linear IgA disease and the pemphigoid group and inflammatory bowel disease: two case reports and literature review. Clin Exp Dermatol. 2012;37:461\u20138.","journal-title":"Clin Exp Dermatol"},{"key":"1089_CR36","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1046\/j.1365-2133.2000.03928.x","volume":"143","author":"SL Walker","year":"2000","unstructured":"Walker SL, Banerjee P, Harland CC, Black MM. Remission of linear IgA disease associated with ulcerative colitis following panproctocolectomy. Br J Dermatol. 2000;143:1341\u20132.","journal-title":"Br J Dermatol"},{"key":"1089_CR37","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/j.1365-2133.1997.tb03671.x","volume":"136","author":"DG Paige","year":"1997","unstructured":"Paige DG, Leonard JN, Wojnarowska F, Fry L. Linear IgA disease and ulcerative colitis. Br J Dermatol. 1997;136:779\u201382.","journal-title":"Br J Dermatol"},{"key":"1089_CR38","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3109\/00365529609051998","volume":"31","author":"G Trallori","year":"1996","unstructured":"Trallori G, Palli D, Saieva C, et al. A population-based study of inflammatory bowel disease in Florence over 15 years (1978\u201392). Scand J Gastroenterol. 1996;31:892\u20139.","journal-title":"Scand J Gastroenterol"},{"key":"1089_CR39","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s40257-016-0235-z","volume":"18","author":"S Kartan","year":"2017","unstructured":"Kartan S, Shi VY, Clark AK, Chan LS. Paraneoplastic pemphigus and autoimmune blistering diseases associated with neoplasm: characteristics, diagnosis, associated neoplasms, proposed pathogenesis, treatment. Am J Clin Dermatol. 2017;18:105\u201326.","journal-title":"Am J Clin Dermatol"},{"key":"1089_CR40","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1600-0560.1990.tb00073.x","volume":"17","author":"E Willsteed","year":"1990","unstructured":"Willsteed E, Bhogal BS, Black MM, McKee P, Wojnarowska F. Use of 1M NaCl split skin in the indirect immunofluorescence of the linear IgA bullous dermatoses. J Cutan Pathol. 1990;17:144\u20138.","journal-title":"J Cutan Pathol"},{"key":"1089_CR41","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1365-2230.2007.02428.x","volume":"32","author":"A Lally","year":"2007","unstructured":"Lally A, Chamberlain A, Allen J, Dean D, Wojnarowska F. Dermal-binding linear IgA disease: an uncommon subset of a rare immunobullous disease. Clin Exp Dermatol. 2007;32:493\u20138.","journal-title":"Clin Exp Dermatol"},{"key":"1089_CR42","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/jid.2014.381","volume":"135","author":"A Tsuchisaka","year":"2015","unstructured":"Tsuchisaka A, Ohara K, Ishii N, et al. Type VII collagen is the major autoantigen for sublamina densa-type linear IgA bullous dermatosis. J Invest Dermatol. 2015;135:626\u20139.","journal-title":"J Invest Dermatol"},{"key":"1089_CR43","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1067\/mjd.2002.125079","volume":"47","author":"RM Vodegel","year":"2002","unstructured":"Vodegel RM, de Jong MC, Pas HH, Jonkman MF. IgA-mediated epidermolysis bullosa acquisita: two cases and review of the literature. J Am Acad Dermatol. 2002;47:919\u201325.","journal-title":"J Am Acad Dermatol"},{"key":"1089_CR44","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fmed.2018.00362","volume":"5","author":"H Koga","year":"2019","unstructured":"Koga H, Prost-Squarcioni C, Iwata H, Jonkman MF, Ludwig RJ, Bieber K. Epidermolysis bullosa Acquisita: the 2019 update. Front Med (Lausanne). 2019;5:362.","journal-title":"Front Med (Lausanne)"},{"key":"1089_CR45","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1159\/000350818","volume":"226","author":"E Antiga","year":"2013","unstructured":"Antiga E, Caproni M, Fabbri P. Linear immunoglobulin a bullous dermatosis: need for an agreement on diagnostic criteria. Dermatology. 2013;226:329\u201332.","journal-title":"Dermatology."},{"key":"1089_CR46","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/odi.12193","volume":"20","author":"G Di Zenzo","year":"2014","unstructured":"Di Zenzo G, Carrozzo M, Chan LS. Urban legend series: mucous membrane pemphigoid. Oral Dis. 2014;20:35\u201354.","journal-title":"Oral Dis"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1089-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1089-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1089-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T15:54:27Z","timestamp":1663516467000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1089-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,24]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1089"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1089-2","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,24]]},"assertion":[{"value":"4 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in accordance with the Declaration of Helsinki and the full protocol was approved by the Institutional Review Board of the Fondazione IRCCS Ca\u2032 Granda Ospedale Maggiore Policlinico, Milan, Italy. All the subjects enrolled in the study gave their written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"115"}}